SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-16-590586
Filing Date
2016-05-13
Accepted
2016-05-13 17:24:16
Documents
2
Period of Report
2016-06-30
Effectiveness Date
2016-05-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A d168972ddef14a.htm DEF 14A 621123
2 GRAPHIC g168972g50m44.jpg GRAPHIC 24343
  Complete submission text file 0001193125-16-590586.txt   655911
Mailing Address 9380 JUDICIAL DRIVE SAN DIEGO CA 92121
Business Address 9380 JUDICIAL DRIVE SAN DIEGO CA 92121 858-210-3700
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36150 | Film No.: 161649633
SIC: 8731 Services-Commercial Physical & Biological Research